The National Health Insurance Administration held a press conference to release the 3.0 version of the disease-specific payment grouping plan and technical specifications. This is the third edition of the grouping scheme and technical specification after the 1.0 version of the 2019 cluster plan and the 2024 2.0 version of the grouping plan. Payment by disease type has basically achieved “full coverage” of eligible co-ordinated regions and medical institutions. In 2019, a pilot project for countries paying by patient group was launched, in 2020, and a three-year action plan to reform health insurance payment methods was launched in 2021 to speed up reform, expansion and quality improvement on the basis of the pilot. After three years of pilot and three years of special action, payment by disease type has basically achieved “full coverage” of eligible co-ordinated regions and medical institutions. In 2025, the number of people paying by disease type already accounted for 91.8% of the total number of medical insurance discharges. The individual burden on patients has been reduced, and the structure of hospitalization expenses in medical institutions is more reasonable. Judging from the results of the reform, a win-win situation for medical treatment, insurance, and patients has initially been achieved. First, the personal burden on patients has been reduced. In 2025, the average hospital expenses for employee health insurance and residents' health insurance decreased by 4.73% and 0.94% respectively compared to 2024, and the absolute amount of expenses borne by hospitalized patients in 28 provinces decreased; second, the hospitalization cost structure of medical institutions was more reasonable. In 2025, drug consumption costs accounted for about 37.49% of the hospitalization costs of cases paid by disease type nationwide, down 0.52 percentage points from the previous year. The total cost of hospitalization in 22 provinces showed a structural change of “a decrease in the proportion of medication consumption and an increase in the share of medical service expenses”; the third is a special case. Single discussion, etc. The mechanism strongly guarantees the treatment of critically ill patients and the application of innovative technology and drug consumption. The special case single review mechanism has now been widely established across the country. In 2025, medical institutions applied for 2.674 million special cases, with a pass rate of 86.9%. The health insurance fund settlement was about 64.473 billion yuan, and the average health insurance fund expenditure was about 27,700 yuan. At the same time, health insurance funds are generally running smoothly. In 2025, the total revenue of the national basic health insurance fund is 3.59 trillion yuan, and the total expenditure is about 3 trillion yuan.